Rhythm

RHY.AX

Tags: AU Healthcare Medical - Diagnostics & Research

Rhythm Biosciences Limited Price (RHY.AX)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

228,296,917

(3.0492)%

Market Cap of Rhythm (RHY.AX)

Market cap:

As of , RHY.AX has a market cap of . This makes RHY.AX the 1015th most valuable company in the AU by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Rhythm Biosciences Limited, a transformative predictive cancer diagnostics technology company in Australia and internationally. The company engages in developing and commercializing medical diagnostics technology. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Parkville, Australia. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $0.042-0.14
Market Cap 24.37M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Medical - Diagnostics & Research

ceo: Dr. David Atkins M.B.A., Ph.D.
IPO Date: December, 06, 2017
Country: AU
Currency: AUD
Headquaters: Parkville, VIC
Employees: No Data

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: